Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.
The company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. Products marketed to over 180 countries.